Yücel Arman

420 total citations
31 papers, 299 citations indexed

About

Yücel Arman is a scholar working on Epidemiology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Yücel Arman has authored 31 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 8 papers in Cardiology and Cardiovascular Medicine and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Yücel Arman's work include Adipokines, Inflammation, and Metabolic Diseases (7 papers), Inflammation biomarkers and pathways (5 papers) and Pancreatitis Pathology and Treatment (4 papers). Yücel Arman is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (7 papers), Inflammation biomarkers and pathways (5 papers) and Pancreatitis Pathology and Treatment (4 papers). Yücel Arman collaborates with scholars based in Türkiye, Antigua and Barbuda and Somalia. Yücel Arman's co-authors include Tufan Tükek, Murat Akarsu, Murat Köse, Samim Emet, Mustafa Özcan, Timur Selçuk Akpınar, Fatih Özçelik, Mete Özcan, Adem Atıcı and Meral Mert and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and Cytokine.

In The Last Decade

Yücel Arman

27 papers receiving 285 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yücel Arman Türkiye 9 119 91 70 65 60 31 299
Samim Emet Türkiye 10 148 1.2× 108 1.2× 25 0.4× 37 0.6× 104 1.7× 36 320
Yoshinori Kakutani Japan 10 43 0.4× 51 0.6× 42 0.6× 72 1.1× 66 1.1× 21 297
Bo Kyeong Koo South Korea 7 29 0.2× 126 1.4× 74 1.1× 76 1.2× 54 0.9× 7 350
Stamatios Lampsas Greece 11 51 0.4× 112 1.2× 21 0.3× 50 0.8× 161 2.7× 35 389
О. Е. Акбашева Russia 9 67 0.6× 96 1.1× 63 0.9× 102 1.6× 210 3.5× 42 319
Emma Fletcher United States 11 73 0.6× 55 0.6× 86 1.2× 130 2.0× 31 0.5× 27 356
Rosalie M. Kiewiet Netherlands 8 76 0.6× 71 0.8× 126 1.8× 102 1.6× 20 0.3× 11 385
Paul Wadwa United States 4 41 0.3× 46 0.5× 85 1.2× 178 2.7× 160 2.7× 4 378
A. Zuccarelli Italy 10 31 0.3× 84 0.9× 100 1.4× 73 1.1× 112 1.9× 14 428
Elisabetta Stenner Italy 10 35 0.3× 63 0.7× 50 0.7× 22 0.3× 111 1.9× 48 316

Countries citing papers authored by Yücel Arman

Since Specialization
Citations

This map shows the geographic impact of Yücel Arman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yücel Arman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yücel Arman more than expected).

Fields of papers citing papers by Yücel Arman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yücel Arman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yücel Arman. The network helps show where Yücel Arman may publish in the future.

Co-authorship network of co-authors of Yücel Arman

This figure shows the co-authorship network connecting the top 25 collaborators of Yücel Arman. A scholar is included among the top collaborators of Yücel Arman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yücel Arman. Yücel Arman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Özcan, Mustafa, et al.. (2025). The Association Between Depression and Antidiabetic Treatments in Type 2 Diabetes Patients with Both Good and Poor Glycemic Control. Journal of Clinical Medicine. 14(10). 3460–3460. 1 indexed citations
2.
Arman, Yücel, et al.. (2022). O Nível de Endocan Sérico pode ser Usado como Biomarcador para Prever Aterosclerose Subclínica em Pacientes Pré-Diabéticos?. Arquivos Brasileiros de Cardiologia. 119(4). 544–550. 5 indexed citations
3.
Arman, Yücel, et al.. (2022). Diagnostic and prognostic value of Nesfatin-1 in sepsis and septic shock. Journal of Experimental and Clinical Medicine. 39(1). 1–6.
4.
Arman, Yücel, et al.. (2021). The relationship between sarcopenia and nesfatin-1 and ghrelin levels in patients with chronic obstructive pulmonary disease. Journal of Health Sciences and Medicine. 4(4). 402–407. 1 indexed citations
5.
Arman, Yücel, et al.. (2021). THE RELATIONSHIP BETWEEN sTREM-1 AND ACTIVATION OF INFLAMMATORY BOWEL DISEASES. SHILAP Revista de lepidopterología. 84(3). 318–323.
6.
Arman, Yücel, et al.. (2021). Correlation of glycemic regulation and endotrophin in patients with type 2 Diabetes; pilot study. Diabetology & Metabolic Syndrome. 13(1). 9–9. 9 indexed citations
7.
Arman, Yücel, et al.. (2021). The association of laminin levels with insulin resistance and non-alcoholic hepatosteatosis. Diabetology & Metabolic Syndrome. 13(1). 60–60. 2 indexed citations
8.
Atıcı, Adem, et al.. (2020). Multilayer global longitudinal strain assessment of subclinical myocardial dysfunction related to insulin resistance. International journal of cardiac imaging. 37(2). 539–546. 3 indexed citations
9.
Akarsu, Murat, Mehmet Hurşitoğlu, Mustafa Özcan, et al.. (2019). Relationships among oncostatin M, insulin resistance, and chronic inflammation: a pilot study. Archives of Endocrinology and Metabolism. 64(1). 253–253. 7 indexed citations
10.
Arman, Yücel, et al.. (2019). Serum Adropin Levels Are Reduced in Adult Patients with Nonalcoholic Fatty Liver Disease. Medical Principles and Practice. 28(5). 463–469. 29 indexed citations
11.
Akarsu, Murat, et al.. (2019). The effects of overt hypothyroidism on adipose tissue and serum betatrophin levels. SHILAP Revista de lepidopterología. 1 indexed citations
12.
Arman, Yücel, et al.. (2018). Serum Angiopoietin-like peptide 4 levels in patients with hepatic steatosis. Cytokine. 111. 496–499. 22 indexed citations
13.
Akarsu, Murat, et al.. (2018). Türk hipertansiyon uzlaşı raporu kılavuzluğunda tedavi seçimi: Önerilere ne kadar uyuyoruz?. 46(1). 25–31. 1 indexed citations
14.
Atıcı, Adem, Samim Emet, Murat Akarsu, et al.. (2018). Type I cardiorenal syndrome in patients with acutely decompensated heart failure: the importance of new renal biomarkers.. PubMed. 22(11). 3534–3543. 13 indexed citations
15.
Arman, Yücel, et al.. (2017). COST-EFFECTIVENESS ANALYSIS OF TYPE 2 DIABETES IN OUTPATIENT THERAPY IN TURKEY. Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi. 80(3). 92–97.
16.
Arman, Yücel, Timur Selçuk Akpınar, Murat Köse, et al.. (2015). Effect of Glycemic Regulation on Endocan Levels in Patients With Diabetes. Angiology. 67(3). 239–244. 44 indexed citations
17.
Arman, Yücel, et al.. (2013). Estimation of Cognitive Functions and Effective Factors in Middle and Advance Aged Hypertensive Patients. Journal of the American College of Cardiology. 62(18). C87–C88. 1 indexed citations
18.
Mert, Meral, et al.. (2012). Screening for Cushing’s syndrome in obese type 2 diabetic patients and the predictive factors on the degree of serum cortisol suppression. International Journal of Diabetes in Developing Countries. 32(4). 199–202. 3 indexed citations
19.
Mert, Meral, et al.. (2011). Liver abscess due to Yersinia bacteremia in a well-controlled type I diabetic patient.. PubMed. 62(4). 357–60. 5 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026